When did Design Therapeutics, Inc. report Q4 2024 earnings?

Design Therapeutics, Inc. (DSGN) reported Q4 2024 earnings on March 10, 2025 before market open.

What were Design Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Design Therapeutics, Inc. reported revenue of - and eps of $-0.24 for Q4 2024.

Did Design Therapeutics, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.28 by $0.04.

Where can I find Design Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-035910) directly on SEC EDGAR. The filing index links above go to sec.gov.

Design Therapeutics, Inc. DSGN Q4 2024 Annual earnings

Reported March 10, 2025 · Before market open

Revenue-

EPS-$0.24Beat by $0.04

EPS estimate-$0.28

Next report

Aug 6, 2026 (In 1 week)

EPS estimate-$0.36

Financials

Q4 2024

Income statement

See full

Revenue-—

Operating income-$16.7M-10.4%

Net income-$13.7M-15.3%

EPS (diluted)-$0.24-14.3%

Balance sheet

See full

Cash & equivalents$22.6M+6.4%

Total debt$2.3M-23.5%

Total equity$242.1M-12.8%

Total assets$252.1M-13.0%

Cash flow

See full

Operating cash flow-$9.9M+23.0%

Free cash flow-$9.9M+23.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$349.35M+135%

Enterprise value$329.12M+153%

Returns & leverage

See full

Return on equity-19.1%-2.3pp

Debt / equity0×0.0×

Current ratio29.3×-0.3×

Versus estimates

Diluted EPS

Q1 2026-$0.29Beat by $0.07 Q4 2025-$0.27Beat by $0.11 Q3 2025-$0.30Beat by $0.04 Q2 2025-$0.34Miss by $0.02 Q1 2025-$0.31Miss by $0.03

Q4 2024-$0.24Beat by $0.04

Ask the moment Design Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Design Therapeutics, Inc. report Q4 2024 earnings?: Design Therapeutics, Inc. (DSGN) reported Q4 2024 earnings on March 10, 2025 before market open.
What were Design Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Design Therapeutics, Inc. reported revenue of - and eps of $-0.24 for Q4 2024.
Did Design Therapeutics, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.28 by $0.04.
Where can I find Design Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-035910) directly on SEC EDGAR. The filing index links above go to sec.gov.